Tag: JEFF STROVEL

TEDCO Invests $500,000 in Irazú Oncology to Advance Cancer Therapies

Mar 6, 2025

—

by

Oliver Henderson

in general invests

TEDCO has invested $500,000 in Irazú Oncology through its LSIF to enhance cancer therapies. CEO Jeff Strovel praised TEDCO’s role in advancing their platform. Operating from the University of Maryland BioPark, Irazú focuses on innovative cancer immunotherapy through unique technology. TEDCO seeks to support promising life sciences ventures, reinforcing Maryland’s leadership in the sector. TEDCO,…